ReviewFrontiers in cardiovascular medicine2026
The effects of Traditional Chinese Medicine on cardiac function after percutaneous coronary intervention: a meta-analysis and systematic review.
Review in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This systematic review aimed to synthesize and summarize current evidence regarding the effects of Traditional Chinese Medicine (TCM) on cardiac function in patients with coronary heart disease (CHD) following percutaneous coronary intervention (PCI). Methods: A comprehensive search was conducted in PubMed, Embase, the Cochrane Library, China National Knowledge Infrastructure (CNKI), Wanfang Database, the Chinese Biomedical Literature Database (CBM), and the Chinese Scientific and Technological Journal Database (VIP). Relevant conference papers were also manually screened. Studies evaluating the clinical efficacy of TCM combined with conventional Western medicine for CHD after PCI were selected based on predefined inclusion and exclusion criteria. The methodological quality of the included studies was assessed using the RoB 2. Data extraction was performed independently, and Stata software was used for meta-analysis. Results: 12 studies involving a total of 6,383 patients were included. Compared with conventional Western medicine alone, integrated TCM and Western therapy significantly reduced the incidence of in-stent restenosis (ISR) and non-fatal myocardial infarction after PCI ( Conclusion: The combination of TCM with conventional Western therapy may reduce ISR and non-fatal myocardial infarction in CHD patients after PCI compared with Western medicine alone, suggesting potential benefits for improving post-PCI clinical outcomes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.